On January 27, Skretting announced a collaboration with Proteon Pharmaceuticals to co-develop products using bacteriophage technology to support aquaculture farmers as part of a holistic health strategy.
Biotechnology company Touchlight Genetics LLC and animal health group Stonehaven Incubate AG have formed a new joint venture company called Touchlight Aquaculture, which will develop new vaccine solutions exclusively in the field of aquaculture.
Zoetis announced in early-July the acquisition of Fish Vet Group from Benchmark Holdings, PLC, as a strategic addition to its Pharmaq business which develops and commercialises fish vaccines and offers services in vaccination and diagnostics for aquaculture.
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video